✨
AI Summary
- Tackling drug resistance in oncology with Kairos Pharma.
- ENV-105 resensitizes tumors to hormone therapy.
- Promising progression-free survival in prostate cancer trials.
Guests on This Episode
NB
Neil Bhowmick
1 podcast appearance